DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DESONIDE

« Back to Dashboard

Clinical Trials for Desonide

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00608777	Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)	Terminated	Genentech, Inc.	Phase 4	2008-01-01	The purpose of this study is to determine if calcipotriene/bethamethasone can safely and effectively manage the occurence of LMB (mild localized breakthrough) in patients recieving efalizumab (Raptiva) for moderate to severe plaque psoriasis. It is hypothesized that calcipotriene/betamethasone (Taclonex) could be used to manage LMB and thus allow patients to continue efalizumab without interruption.
NCT00608777	Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)	Terminated	Derm Research, PLLC	Phase 4	2008-01-01	The purpose of this study is to determine if calcipotriene/bethamethasone can safely and effectively manage the occurence of LMB (mild localized breakthrough) in patients recieving efalizumab (Raptiva) for moderate to severe plaque psoriasis. It is hypothesized that calcipotriene/betamethasone (Taclonex) could be used to manage LMB and thus allow patients to continue efalizumab without interruption.
NCT00690833	Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis	Completed	Wake Forest University	Phase 4	2007-08-01	The purpose of this research study is to better understand how this study drug works when people use it to treat atopic dermatitis. Desonate has been approved by the US Food and Drug Administration (FDA) for atopic dermatitis.

Clinical Trial Conditions for Desonide

Condition Name

Condition Name for Desonide
Intervention	Trials
Atopic Dermatitis	2
Eczema	1
Dermatitis, Atopic	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Desonide
Intervention	Trials
Dermatitis, Atopic	3
Dermatitis	3
Eczema	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Desonide

Trials by Country

Trials by Country for Desonide
Location	Trials
United States	9
Mexico	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Desonide
Location	Trials
North Carolina	2
California	1
Massachusetts	1
Texas	1
Ohio	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Desonide

Clinical Trial Phase

Clinical Trial Phase for Desonide
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 1	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Desonide
Clinical Trial Phase	Trials
Completed	3
Unknown status	1
Recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Desonide

Sponsor Name

Sponsor Name for Desonide
Sponsor	Trials
Promius Pharma, LLC	1
Wake Forest University	1
University of California, Davis	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Desonide
Sponsor	Trials
Other	6
Industry	3

Export unavailable in trial.
Subscribe for complete access.